SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 78.98 |
| Enterprise Value ($M) | 172.30 |
| Book Value ($M) | -103.07 |
| Book Value / Share | -1.63 |
| Price / Book | -0.77 |
| NCAV ($M) | -103.31 |
| NCAV / Share | -1.64 |
| Price / NCAV | -0.76 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -14.82 |
| Return on Assets (ROA) | -1.82 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.49 |
| Current Ratio | 0.49 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 17.25 |
| Assets | 17.50 |
| Liabilities | 120.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -42.43 |
| Net Income | -47.05 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -41.77 |
| Cash from Investing | 0.00 |
| Cash from Financing | 31.23 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,600 | 145,987 | 16.17 | |
| 17,406 | 97,589 | 17.84 | |
| 15,400 | 49,435 | 31.15 | |
| 35,206 | 152,664 | 23.06 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FENC – Fennec Pharmaceuticals Inc. | FLGC – Flora Growth Corp. |
| FTLF – FitLife Brands, Inc. | GDTC – CytoMed Therapeutics Limited |
| GELS – Gelteq Limited |